Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes — Stella

Home/PreDiabetes/The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

View on ClinicalTrials.gov

Recruiting

Back to PreDiabetes trials

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Phase

Safety & dosing

Sponsor

Mayo Clinic

Enrollment target

~60 participants

Started

November 2025

Primary completion

October 2027

Age range

25 Years – 70 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.